Unique Gene Expression Patterns in Human T-cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide

Unique Gene Expression Patterns in Human T-cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide

Bibliographic Details
Main Authors:	Mathilda Mandel, Anat Achiron, Gad Lavie, Irun R. Cohen, Michael Gurevich
Format:	Article
Language:	English
Published:	Hindawi Limited 2005-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1080/17402520500233460

Similar Items

Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation.
by: Naama Dror, et al.
Published: (2013-01-01)

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
by: Anat Achiron, et al.
Published: (2009-01-01)

Coronavirus 2019 outbreak pathogenesis: Why China and Italy?
by: Anat Achiron, et al.
Published: (2020-08-01)

Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
by: Tilda Barliya, et al.
Published: (2011-01-01)

MOG-IgG associated optic neuritis is not multiple sclerosis
by: Bruna Klein da Costa, et al.

Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosis.
by: Anat Achiron, et al.
Published: (2012-01-01)

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
by: Or-Bach Rotem, et al.
Published: (2009-07-01)

Axonal loss and neurodegeneration in the Mog-induced EAE model of multiple sclerosis
by: Papadopoulos, Dimitrios
Published: (2003)

Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
by: Naftali Kaminski, et al.
Published: (2005-02-01)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
by: Philippe Horellou, et al.
Published: (2021-06-01)

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
by: Anat Achiron, et al.
Published: (2021-04-01)

Understanding Autoimmune Mechanisms in Multiple Sclerosis Using Gene Expression Microarrays: Treatment Effect and Cytokine-related Pathways
by: A. Achiron, et al.
Published: (2004-01-01)

Advances in Microbial Biofilm Prevention on Indwelling Medical Devices with Emphasis on Usage of Acoustic Energy
by: Gad Lavie, et al.
Published: (2009-04-01)

Injury to white matter tracts in relapsing–remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics
by: Achiron Asaf, et al.
Published: (2015-01-01)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
by: Anat Achiron, et al.
Published: (2021-05-01)

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis
by: Anat Achiron, et al.
Published: (2010-05-01)

Anti-MOG associated myelitis
by: A. I. Isaykin, et al.
Published: (2020-06-01)

Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis
by: Tal Blecher, et al.
Published: (2019-07-01)

Stable Transfection of pEGFP-N1-MOG Plasmid to Utilize in Multiple Sclerosis Gene Therapy
by: Mohammad Hassan Karimfar, et al.
Published: (2015-02-01)

Self and Body Esteem Perception in Multiple Sclerosis
by: Yoram Barak, et al.
Published: (1999-01-01)

On the gravitational instability in the Newtonian limit of MOG
by: Fatimah Shojai, et al.
Published: (2017-07-01)

MOG antibody associated disorder (MOGAD)
by: Lilley Kate, et al.
Published: (2021-01-01)

The role of myelin oligodendrocyte glycoprotein (MOG) in the progression and chronicity of neurological disease in a murine model of multiple sclerosis
by: Smith, Paul Alfred
Published: (2004)

Anti-MOG syndrome: two case reports
by: A. S. Kotov
Published: (2019-03-01)

Regular rotating MOG dark compact object
by: J. W. Moffat
Published: (2021-02-01)

Anti-MOG syndrome: a road to be paved
by: Tarso Adoni

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
by: Christoph Buerth, et al.
Published: (2016-01-01)

Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.
by: Krista G Haanstra, et al.
Published: (2013-01-01)

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
by: Anat Achiron, et al.
Published: (2013-01-01)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
by: Livnat Brill, et al.
Published: (2021-01-01)

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
by: S. Jarius, et al.
Published: (2018-03-01)

”Ohistoriskt mög” - Kontrafaktisk historia som pedagogisk metod
by: Gunnerdal, Hans, et al.
Published: (2010)

Kerr-MOG black holes with stationary scalar clouds
by: Xiongying Qiao, et al.
Published: (2020-06-01)

Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
by: Marie Cathrin Mayer, et al.
Published: (2012-05-01)

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
by: Marco A. Lana-Peixoto, et al.
Published: (2019-06-01)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
by: S. Jarius, et al.
Published: (2018-05-01)

Quasinormal modes of modified gravity (MOG) black holes
by: Luciano Manfredi, et al.
Published: (2018-04-01)

Cosmological Observations in a Modified Theory of Gravity (MOG)
by: John. W. Moffat, et al.
Published: (2013-06-01)

Particle dynamics near Kerr-MOG black hole
by: M. Sharif, et al.
Published: (2017-05-01)

MOG Platform using Mobile Agents for Resource Transactions
by: Yu Chieh Kao, et al.
Published: (2007)